Award
NIH Reporter #5R01CA276279-04
The Role of Egfl6 in Tumor Immunity
Recipient
Not specified
Award Amount
$311,352.00
Ceiling
$311,352.00
Awarded
May 27, 2026
Identifier
5R01CA276279-04
NIH grant awarded by the National Cancer Institute to study the role of Egfl6 in tumor immunity, aiming to improve immunotherapy for ovarian cancer.
Description
This is a NIH grant project focusing on ovarian cancer and tumor immunology, specifically investigating the role of Egfl6 in tumor immune suppression and its potential as a therapeutic target to enhance immunotherapy efficacy.